Mersana Therapeutics Announces Initiation of Expansion Study of XMT-1536 in Patients with Platinum-Resistant Ovarian Cancer and Non-Small Cell Lung Cancer

August 20, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search